# Pharmacokinetics and Safety of Desvenlafaxine in Korean Healthy Subjects Following Single and Multiple Oral Doses of Desvenlafaxine Succinate Sustained Release Tablet

> **NCT01443208** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 36 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** desvenlafaxine
- **DRUG:** desvenlafaxine
- **DRUG:** desvenlafaxine

## Key facts

- **NCT ID:** NCT01443208
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2012-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01443208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01443208, "Pharmacokinetics and Safety of Desvenlafaxine in Korean Healthy Subjects Following Single and Multiple Oral Doses of Desvenlafaxine Succinate Sustained Release Tablet". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01443208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*